244 related articles for article (PubMed ID: 35994213)
1. Metadata analysis to explore hub of the hub-genes highlighting their functions, pathways and regulators for cervical cancer diagnosis and therapies.
Reza MS; Hossen MA; Harun-Or-Roshid M; Siddika MA; Kabir MH; Mollah MNH
Discov Oncol; 2022 Aug; 13(1):79. PubMed ID: 35994213
[TBL] [Abstract][Full Text] [Related]
2. Identification of host transcriptome-guided repurposable drugs for SARS-CoV-1 infections and their validation with SARS-CoV-2 infections by using the integrated bioinformatics approaches.
Ahmed FF; Reza MS; Sarker MS; Islam MS; Mosharaf MP; Hasan S; Mollah MNH
PLoS One; 2022; 17(4):e0266124. PubMed ID: 35390032
[TBL] [Abstract][Full Text] [Related]
3. Robust Identification of Differential Gene Expression Patterns from Multiple Transcriptomics Datasets for Early Diagnosis, Prognosis, and Therapies for Breast Cancer.
Tuly KF; Hossen MB; Islam MA; Kibria MK; Alam MS; Harun-Or-Roshid M; Begum AA; Hasan S; Mahumud RA; Mollah MNH
Medicina (Kaunas); 2023 Sep; 59(10):. PubMed ID: 37893423
[No Abstract] [Full Text] [Related]
4. Bioinformatics Screening of Potential Biomarkers from mRNA Expression Profiles to Discover Drug Targets and Agents for Cervical Cancer.
Reza MS; Harun-Or-Roshid M; Islam MA; Hossen MA; Hossain MT; Feng S; Xi W; Mollah MNH; Wei Y
Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409328
[TBL] [Abstract][Full Text] [Related]
5. Identification of host genomic biomarkers from multiple transcriptomics datasets for diagnosis and therapies of SARS-CoV-2 infections.
Sarker B; Rahaman MM; Islam MA; Alamin MH; Husain MM; Ferdousi F; Ahsan MA; Mollah MNH
PLoS One; 2023; 18(3):e0281981. PubMed ID: 36913345
[TBL] [Abstract][Full Text] [Related]
6. Computational identification of host genomic biomarkers highlighting their functions, pathways and regulators that influence SARS-CoV-2 infections and drug repurposing.
Mosharaf MP; Reza MS; Kibria MK; Ahmed FF; Kabir MH; Hasan S; Mollah MNH
Sci Rep; 2022 Mar; 12(1):4279. PubMed ID: 35277538
[TBL] [Abstract][Full Text] [Related]
7. Disclosing Potential Key Genes, Therapeutic Targets and Agents for Non-Small Cell Lung Cancer: Evidence from Integrative Bioinformatics Analysis.
Mosharaf MP; Reza MS; Gov E; Mahumud RA; Mollah MNH
Vaccines (Basel); 2022 May; 10(5):. PubMed ID: 35632527
[TBL] [Abstract][Full Text] [Related]
8. Screening and verifying key genes with poor prognosis in colon cancer through bioinformatics analysis.
Dong B; Chai M; Chen H; Feng Q; Jin R; Hu S
Transl Cancer Res; 2020 Nov; 9(11):6720-6732. PubMed ID: 35117282
[TBL] [Abstract][Full Text] [Related]
9. Identification of key molecular markers in epithelial ovarian cancer by integrated bioinformatics analysis.
Qin W; Yuan Q; Liu Y; Zeng Y; Ke D; Dai X; Shuai Y; Hu J; Shi H
Taiwan J Obstet Gynecol; 2021 Nov; 60(6):983-994. PubMed ID: 34794761
[TBL] [Abstract][Full Text] [Related]
10. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
[TBL] [Abstract][Full Text] [Related]
11. Screening of cervical cancer-related hub genes based on comprehensive bioinformatics analysis.
Tu S; Zhang H; Yang X; Wen W; Song K; Yu X; Qu X
Cancer Biomark; 2021; 32(3):303-315. PubMed ID: 34151839
[TBL] [Abstract][Full Text] [Related]
12. Identification of Five Hub Genes as Key Prognostic Biomarkers in Liver Cancer via Integrated Bioinformatics Analysis.
Nguyen TB; Do DN; Nguyen-Thanh T; Tatipamula VB; Nguyen HT
Biology (Basel); 2021 Sep; 10(10):. PubMed ID: 34681056
[TBL] [Abstract][Full Text] [Related]
13. Statistics and network-based approaches to identify molecular mechanisms that drive the progression of breast cancer.
Alam MS; Rahaman MM; Sultana A; Wang G; Mollah MNH
Comput Biol Med; 2022 Jun; 145():105508. PubMed ID: 35447458
[TBL] [Abstract][Full Text] [Related]
14. Integrated analysis of key microRNAs /TFs /mRNAs/ in HPV-positive cervical cancer based on microRNA sequencing and bioinformatics analysis.
Yuan Y; Shi X; Li B; Peng M; Zhu T; Lv G; Liu L; Jin H; Li L; Qin D
Pathol Res Pract; 2020 Jun; 216(6):152952. PubMed ID: 32307200
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive Analysis of Candidate Diagnostic and Prognostic Biomarkers Associated with Lung Adenocarcinoma.
Li J; Liu X; Cui Z; Han G
Med Sci Monit; 2020 Jun; 26():e922070. PubMed ID: 32578582
[TBL] [Abstract][Full Text] [Related]
16. A microRNA-Messenger RNA Regulatory Network and Its Prognostic Value in Cervical Cancer.
Liu J; Yang J; Gao F; Li S; Nie S; Meng H; Sun R; Wan Y; Jiang Y; Ma X; Cheng W
DNA Cell Biol; 2020 Jul; 39(7):1328-1346. PubMed ID: 32456463
[TBL] [Abstract][Full Text] [Related]
17. Meta-Data Analysis to Explore the Hub of the Hub-Genes That Influence SARS-CoV-2 Infections Highlighting Their Pathogenetic Processes and Drugs Repurposing.
Mosharaf MP; Kibria MK; Hossen MB; Islam MA; Reza MS; Mahumud RA; Alam K; Gow J; Mollah MNH
Vaccines (Basel); 2022 Aug; 10(8):. PubMed ID: 36016137
[TBL] [Abstract][Full Text] [Related]
18. Identification of Multiple Hub Genes and Pathways in Hepatocellular Carcinoma: A Bioinformatics Analysis.
Liu J; Han F; Ding J; Liang X; Liu J; Huang D; Zhang C
Biomed Res Int; 2021; 2021():8849415. PubMed ID: 34337056
[TBL] [Abstract][Full Text] [Related]
19. Identification of hub genes in triple-negative breast cancer by integrated bioinformatics analysis.
Wei LM; Li XY; Wang ZM; Wang YK; Yao G; Fan JH; Wang XS
Gland Surg; 2021 Feb; 10(2):799-806. PubMed ID: 33708561
[TBL] [Abstract][Full Text] [Related]
20. Integrative analyses of molecular pathways and key candidate biomarkers associated with colorectal cancer.
Pirim D
Cancer Biomark; 2020; 27(4):555-568. PubMed ID: 32176635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
